JP2018509154A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509154A5
JP2018509154A5 JP2017547425A JP2017547425A JP2018509154A5 JP 2018509154 A5 JP2018509154 A5 JP 2018509154A5 JP 2017547425 A JP2017547425 A JP 2017547425A JP 2017547425 A JP2017547425 A JP 2017547425A JP 2018509154 A5 JP2018509154 A5 JP 2018509154A5
Authority
JP
Japan
Prior art keywords
vector
nucleotide sequence
mammal
motomeko
sequence encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017547425A
Other languages
English (en)
Japanese (ja)
Other versions
JP6935049B2 (ja
JP2018509154A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/022072 external-priority patent/WO2016145345A1/en
Publication of JP2018509154A publication Critical patent/JP2018509154A/ja
Publication of JP2018509154A5 publication Critical patent/JP2018509154A5/ja
Application granted granted Critical
Publication of JP6935049B2 publication Critical patent/JP6935049B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017547425A 2015-03-11 2016-03-11 X連鎖性網膜色素変性症の治療のためのrp2及びrpgrベクター Active JP6935049B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562131661P 2015-03-11 2015-03-11
US62/131,661 2015-03-11
PCT/US2016/022072 WO2016145345A1 (en) 2015-03-11 2016-03-11 Rp2 and rpgr vectors for treating x-linked retinitis pigmentosa

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020167984A Division JP2021019611A (ja) 2015-03-11 2020-10-02 X連鎖性網膜色素変性症の治療のためのrp2及びrpgrベクター

Publications (3)

Publication Number Publication Date
JP2018509154A JP2018509154A (ja) 2018-04-05
JP2018509154A5 true JP2018509154A5 (cg-RX-API-DMAC7.html) 2019-04-18
JP6935049B2 JP6935049B2 (ja) 2021-09-15

Family

ID=56879752

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017547425A Active JP6935049B2 (ja) 2015-03-11 2016-03-11 X連鎖性網膜色素変性症の治療のためのrp2及びrpgrベクター
JP2020167984A Pending JP2021019611A (ja) 2015-03-11 2020-10-02 X連鎖性網膜色素変性症の治療のためのrp2及びrpgrベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020167984A Pending JP2021019611A (ja) 2015-03-11 2020-10-02 X連鎖性網膜色素変性症の治療のためのrp2及びrpgrベクター

Country Status (6)

Country Link
US (2) US10646588B2 (cg-RX-API-DMAC7.html)
EP (2) EP3268481B1 (cg-RX-API-DMAC7.html)
JP (2) JP6935049B2 (cg-RX-API-DMAC7.html)
AU (1) AU2016228751B2 (cg-RX-API-DMAC7.html)
CA (1) CA2979229A1 (cg-RX-API-DMAC7.html)
WO (1) WO2016145345A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3268481B1 (en) 2015-03-11 2020-05-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Rpgr vectors for treating x-linked retinitis pigmentosa
DK3710590T3 (da) * 2017-11-15 2024-08-12 Univ Michigan Regents Virale vektorer omfattende rdh12-kodende områder og fremgangsmåder til behandling af nethindedystrofier
JOP20210054A1 (ar) * 2018-09-21 2020-03-21 Nightstarx Ltd تركيبات وطرق لعلاج التهاب الشبكية الصباغي
CA3131023A1 (en) * 2019-02-22 2020-08-27 Michael R. Volkert Oxr1 gene therapy
AU2020335909A1 (en) * 2019-08-30 2022-04-14 Baylor College Of Medicine System for regulating gene expression
WO2021178668A1 (en) * 2020-03-04 2021-09-10 University Of Massachusetts Compositions and methods for modulating rpgr expression

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722375B2 (en) 1996-09-06 2000-08-03 Trustees Of The University Of Pennsylvania, The Methods using cre-lox for production of recombinant adeno-associated viruses
AU2009209408B2 (en) 2008-01-29 2015-06-11 Beacon Therapeutics Limited Recombinant virus production using mammalian cells in suspension
US20100081707A1 (en) * 2008-02-21 2010-04-01 Ali Robin R Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
US9868937B2 (en) * 2011-05-26 2018-01-16 University Of Washington Cell and gene based methods to improve cardiac function
EP2872183B1 (en) * 2012-07-11 2018-09-26 The Trustees Of The University Of Pennsylvania Aav-mediated gene therapy for rpgr x-linked retinal degeneration
AU2014216160B2 (en) * 2013-02-15 2017-03-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services AAV8 retinoschisin expression vector for treating X-linked retinoschisis
CN105209619B (zh) * 2013-03-11 2018-10-12 泰莱托恩基金会 miR-204和miR-211及其用途
WO2015160893A1 (en) 2014-04-15 2015-10-22 Applied Genetic Technologies Corporation Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr)
IL248102B (en) * 2014-05-02 2022-07-01 Genzyme Corp aav vectors for gene therapy of the central nervous system and retina
GB201412011D0 (en) * 2014-07-04 2014-08-20 Ucl Business Plc Treatments
HUE052781T2 (hu) * 2014-07-24 2021-05-28 Massachusetts Eye & Ear Infirmary RPGR génterápia a retinitis pigmentosa terápiájára
SI3265571T1 (sl) * 2015-03-03 2022-10-28 Fondazione Telethon Več vektorski sistem in njegove uporabe
EP3268481B1 (en) 2015-03-11 2020-05-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Rpgr vectors for treating x-linked retinitis pigmentosa

Similar Documents

Publication Publication Date Title
JP2018509154A5 (cg-RX-API-DMAC7.html)
JP6831779B2 (ja) 修飾された第ix因子、並びに、細胞、器官及び組織への遺伝子導入のための組成物、方法及び使用
JP7374119B2 (ja) 減少した肝臓向性を有するAAV9とAAVrh74とのハイブリッド組換えアデノ随伴ウイルス血清型
US20220331409A1 (en) Factor ix gene therapy
JP2020514286A5 (cg-RX-API-DMAC7.html)
JP6805174B2 (ja) 神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むaav分離株及び融合タンパク質
JP2016538885A5 (cg-RX-API-DMAC7.html)
JP2015523379A5 (cg-RX-API-DMAC7.html)
JP2019523648A5 (cg-RX-API-DMAC7.html)
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
JP2018537984A5 (cg-RX-API-DMAC7.html)
JP2019524090A5 (cg-RX-API-DMAC7.html)
CA3024449A1 (en) Compositions and methods of treating huntington's disease
JP2018512125A (ja) 多重ベクターシステム及びその使用
KR20160033217A (ko) 변종 aav 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도
KR20170084012A (ko) 지혈 장애의 치료를 위한 변이체 인자 viii의 패키징 및 발현을 위한 개선된 발현 카세트
JP2019502378A5 (cg-RX-API-DMAC7.html)
JP2020073536A5 (cg-RX-API-DMAC7.html)
JP2018510620A5 (cg-RX-API-DMAC7.html)
JP2021500922A5 (cg-RX-API-DMAC7.html)
JP2017523239A5 (cg-RX-API-DMAC7.html)
JP2022529782A (ja) シュタルガルト病(abca4)の遺伝子治療
JP2018533976A5 (cg-RX-API-DMAC7.html)
JP2023076698A (ja) 21-ヒドロキシラーゼ欠損症のためのアデノ随伴ウイルス遺伝子療法
JP2021502978A5 (cg-RX-API-DMAC7.html)